The University of Missouri School of Medicine Department of Radiology includes some of the nation’s leading scientists in the areas of radiological imaging, therapeutics, chemistry, nanomedicine, and molecular medicine.
They have been leaders in producing several widely used radiopharmaceuticals, including: Ceretec™, the first brain imaging agent; TheraSphere®, a treatment for liver cancer; and Quadramet®, an agent designed to relieve the excruciating pain associated with metastatic bone cancer.
Our researchers benefit from unique resources located on the MU campus:
- University of Missouri Research Reactor, the most powerful university research reactor in the country
- One of the nation’s most advanced biomolecular imaging centers, which produces high resolution anatomic and molecular images of rodents for radiopharmaceutical and other biomedical research
- Radiopharmaceutical Sciences Institute, which serves as as a catalyst for development of world-class interdisciplinary research and educational programs
- International Institute of Nano and Molecular Medicine
- Translational Neuroscience Center